课题基金 / 基金详情

Investigating white matter structural differences in treatment-resistant schizophrenia and ultra-resistant schizophrenia

Investigating white matter structural differences in treatment-resistant schizophrenia and ultra-resistant schizophrenia
研究难治性精神分裂症和超难治性精神分裂症的白质结构差异
批准号：
300741
负责人：
Takeuchi Hiroyoshi
金额：
$12.02万
依托单位：
Centre for Addiction and Mental Health (Toronto)
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2013
资助国家：
加拿大
项目状态：
已结题
起止时间：
2013-11-01 至 2016-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=300741&lang=en
关键词：
Clozapine Diffusion Tensor Imaging (Dti) Magnetic Resonance Imaging (Mri) Schizophrenia Treatment-Resistant Schizophrenia (Trs) Ultra-Resistant Schizophrenia (Urs) White Matter

项目摘要

项目成果

Takeuchi Hiroyoshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Approximately 30% of patients with schizophrenia do not optimally respond to antipsychotics, which is called treatment-resistant schizophrenia (TRS). Clozapine is a unique antipsychotic drug, which has been demonstrated to have greater efficacy for TRS, w
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigating white matter structural differences in treatment-resistant schizophrenia and ultra-resistant schizophrenia
海外基金